Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) trans 1 yn 4 en eicosan 3 ol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.